2616-79-7
2616-79-7 structure
- Name: 3-ALPHA-HYDROXY-6-OXO-5-ALPHA-CHOLAN-24-OIC ACID METHYL ESTER 3-ACETATE
- Chemical Name: methyl (4R)-4-[(3R,5S,8S,9S,10R,13R,14S,17R)-3-acetyloxy-10,13-dimethyl-6-oxo-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
- CAS Number: 2616-79-7
- Molecular Formula: C27H42O5
- Molecular Weight: 446.62
- Catalog: Research Areas Others
- Create Date: 2018-12-29 10:08:05
- Modify Date: 2024-04-03 12:52:18
-
Methyl (3α,5α)-3-(acetyloxy)-6-oxocholan-24-oate is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
| Name | methyl (4R)-4-[(3R,5S,8S,9S,10R,13R,14S,17R)-3-acetyloxy-10,13-dimethyl-6-oxo-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate |
|---|---|
| Synonyms |
3alpha-Hydroxy-6-oxo-5alpha-cholan-24-oic acid methyl ester 3-acetate
Methyl 3|A-acetoxy-6-oxo-5|A-cholanate 5|A-Cholanic acid-3|A-ol-6-one 3-acetate methyl ester 3|A-Hydroxy-6-oxo-5|A-cholan-24-oic acid methyl ester 3-acetate 5alpha-Cholanic acid-3alpha-ol-6-one 3-acetate methyl ester Methyl 3alpha-acetoxy-6-oxo-5alpha-cholanate |
| Description | Methyl (3α,5α)-3-(acetyloxy)-6-oxocholan-24-oate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.1g/cm3 |
|---|---|
| Boiling Point | 516.8ºC at 760 mmHg |
| Molecular Formula | C27H42O5 |
| Molecular Weight | 446.62 |
| Flash Point | 217.8ºC |
| Exact Mass | 446.30300 |
| PSA | 69.67000 |
| LogP | 5.34530 |
| Vapour Pressure | 8.68E-11mmHg at 25°C |
| Index of Refraction | 1.519 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~92%
2616-79-7 |
| Literature: SAGE THERAPEUTICS, INC.; UPASANI, Ravindra, B.; HARRISON, Boyd, L.; ASKEW, Benny, C. Jr.; DODART, Jean-Cosme; SALITURO, Francesco, G.; ROBICHAUD, Albert, J. Patent: WO2013/36835 A1, 2013 ; Location in patent: Page/Page column 178; 179; 180 ; |
|
~%
2616-79-7 |
| Literature: SAGE THERAPEUTICS, INC.; UPASANI, Ravindra, B.; HARRISON, Boyd, L.; ASKEW, Benny, C. Jr.; DODART, Jean-Cosme; SALITURO, Francesco, G.; ROBICHAUD, Albert, J. Patent: WO2013/36835 A1, 2013 ; |
|
~%
2616-79-7 |
| Literature: SAGE THERAPEUTICS, INC.; UPASANI, Ravindra, B.; HARRISON, Boyd, L.; ASKEW, Benny, C. Jr.; DODART, Jean-Cosme; SALITURO, Francesco, G.; ROBICHAUD, Albert, J. Patent: WO2013/36835 A1, 2013 ; |
|
~%
2616-79-7 |
| Literature: SAGE THERAPEUTICS, INC.; UPASANI, Ravindra, B.; HARRISON, Boyd, L.; ASKEW, Benny, C. Jr.; DODART, Jean-Cosme; SALITURO, Francesco, G.; ROBICHAUD, Albert, J. Patent: WO2013/36835 A1, 2013 ; |
|
~%
2616-79-7 |
| Literature: Fernholz Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1935 , vol. 232, p. 202,204 |
|
~%
2616-79-7 |
| Literature: Hoehn; Linsk; Moffett Journal of the American Chemical Society, 1946 , vol. 68, p. 1855 |
| Precursor 7 | |
|---|---|
| DownStream 0 | |